Compounds useful as inhibitors of ATR kinase
US10093676B2 · kind B2 · utility
3Cited by
45References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 17, 2017 |
| Grant date | Oct 9, 2018 |
| Priority date | — |
| Expiry date | May 17, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/55
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and solid forms of the compounds of this invention.The compounds of this invention have formula I-1 or I-A: wherein the variables are as defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.